BioCentury
ARTICLE | Politics & Policy

Azar appoints drug pricing adviser

March 29, 2018 10:34 PM UTC

HHS Secretary Alex Azar appointed Daniel Best as senior adviser for drug pricing reform.

Best was VP of industry relations for the Medicare Part D unit of CVS Caremark, the PBM business of CVS Health Corp. (NYSE:CVS). From 2001-05, he was director of business development at Pfizer Inc. (NYSE:PFE)...

BCIQ Company Profiles

CVS Health Corp.

Pfizer Inc.